about
The serotonergic agent m-chlorophenylpiperazine induces migraine attacks: A controlled studyPlacebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacksTolosa-Hunt syndrome: critical literature review based on IHS 2004 criteriaAre depressive symptomatology, self-efficacy, and perceived social support related to disability and quality of life in patients with chronic migraine associated to medication overuse? Data from a cross-sectional study.Topiramate in migraine prophylaxis: data from a pooled analysis and open-label extension study.Deep brain stimulation in trigeminal autonomic cephalalgias.Costs of hypothalamic stimulation in chronic drug-resistant cluster headache: preliminary data.Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data.Neuroimaging in chronic migraine.Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura.Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan.An innovative approach for migraine prevention in young age: a preliminary study.Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian studyNeuromodulation in drug-resistant primary headaches: what have we learned?A review of hormonal findings in cluster headache. Evidence for hypothalamic involvement.First Italian case of hypnic headache, with literature review and discussion of nosology.Comparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: a randomized study.Efficacy of frovatriptan and other triptans in the treatment of acute migraine of normal weight and obese subjects: a review of randomized studies.Migraine, celiac disease, and cerebral calcifications: a new case.Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study.Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study.Gingkolide B as migraine preventive treatment in young age: results at 1-year follow-up.Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan.Clinical features and outcomes in spontaneous intracranial hypotension: a survey of 90 consecutive patients.Chronic migraine classification: current knowledge and future perspectivesNon-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label studyEfficacy of frovatriptan versus other triptans in the acute treatment of menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies.Frovatriptan versus zolmitriptan for the acute treatment of migraine with aura: a subgroup analysis of a double-blind, randomized, multicenter, Italian studyHeadache, anxiety and depressive disorders: the HADAS study.Early treatment of migraine attacks with triptans: a strategy to enhance outcomes and patient satisfaction?A proposal for a national registry on chronic migraines.Headache with medication overuse: treatment strategies and proposals of relapse prevention.Topiramate in the prevention of migraine: a review of its efficacy, tolerability, and acceptability.Epidemiology of fixed unilateral headaches.Cluster headache: from treatment to pathophysiology.Does closure of a patent foramen ovale have a role in the treatment of migraine with aura?When should "chronic migraine" patients be considered "refractory" to pharmacological prophylaxis?Therapeutic neurostimulation in chronic headaches: problems of patient selection.Long-term experience of neuromodulation in TACs.Cluster headache: pharmacological treatment and neurostimulation.
P50
Q28140634-E4AAFEDF-73F4-4496-AC8B-B323E193C895Q28171147-4DED13C6-690D-448E-8840-A58A79CD8E3EQ28246282-7FB386EF-24D6-4697-8344-4B086A0BC9CBQ30939882-E53DC875-BD2E-4349-812C-7AC6D6B1F486Q31040087-2ADC2E84-2D9E-42A0-8F77-C6349B501961Q33158679-44B0851E-18AF-4E45-9BD6-E5CCF30D2B36Q33438958-D61AC9F7-A96F-44BC-9C9D-030E6C7A9BF8Q33438961-013C2D80-52D2-4545-999C-6CAD921D5AF4Q33577081-0059E9F0-8AB1-4B2F-89EE-11D9F1863997Q33671824-ED338266-6EAC-4B71-BC24-4F69C24BF831Q33847251-8AAF7AFD-79B9-44D0-932E-9EE4EA8F49FCQ33847255-19519970-18C2-4E36-BF9B-22BAC3B968E8Q33847333-5AF4DDA1-AF19-41E1-9D23-A81ED9EC52C1Q34026727-1160DF8D-3CDD-44B5-86A4-FCCBE82CAD19Q34060930-90D520DC-E60B-43F0-8860-6D9B2850CBF8Q34216565-4002BC07-A5B1-4988-9D5A-A8A64DBFBE77Q34393819-DA803ECD-0A31-4E32-9FA2-0E287D24A232Q34421615-28955553-029E-437E-A0A3-3CDE8DFD78E3Q34453107-F528F780-2C76-49E4-9EE9-4BA6A08E360FQ34570781-7EF3B6BC-6A02-4008-9DF2-616198C933FAQ34673690-B4BCA5A2-76DF-403B-A35F-660C2582E873Q34890725-4807E1A4-ED47-480F-87EB-39A260FF7507Q34890784-EF1CD67F-070D-4431-946C-791A6C7107EBQ34979184-B6C08CBB-0B3E-450C-8A85-B2D9E8E3794AQ35522685-2A38F68C-42C3-4E86-86BA-EB792CF1F6F8Q35798612-16C2475F-FE30-448A-9424-54C4F9CE3817Q35996147-C25DD4A3-6903-4F38-88A8-3C2FF30DC953Q35996223-571762A6-DADF-4D69-827A-1CF235DA9C1DQ36261216-15792152-F7C5-425D-9776-D06E5FC89D0AQ36532178-017D099A-2319-4633-A97E-38CFDB3C3277Q36594397-B7E526BB-2B9F-4FE7-B818-994FD3D62781Q37165205-408DBC0F-538E-49D4-91A9-078568E47336Q37165739-6C7BAD8C-3D84-4C37-80F9-356C11CC9136Q37169787-951786BB-5EA8-40E4-BA28-A05F274FA044Q37188586-EEA30344-E443-41C7-A585-ED0D85643FECQ37188603-2728C931-F2C4-454D-8215-FE7B34A06CB8Q37188633-3164CD43-4637-4E6A-8504-3B960A73261AQ37188638-173BB995-FBE8-4F2E-AC3C-2F1746C9E973Q37188642-A0DD1B73-635D-4730-B84B-AE74ABD24A2EQ37406956-0B02922B-6A8F-4121-BF2B-CCB281606E89
P50
description
medical researcher
@en
name
Gennaro Bussone
@en
Gennaro Bussone
@nl
type
label
Gennaro Bussone
@en
Gennaro Bussone
@nl
altLabel
Bussone G
@en
Bussone G.
@en
Bussone
@en
G Bussone
@en
G. Bussone
@en
prefLabel
Gennaro Bussone
@en
Gennaro Bussone
@nl